2023 Q4 Form 10-Q Financial Statement

#000086627323000067 Filed on November 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $175.0M $197.7M
YoY Change -9.7% -5.17%
Cost Of Revenue $164.5M $185.8M
YoY Change -15.73% -4.92%
Gross Profit $10.59M $11.86M
YoY Change -913.29% -8.83%
Gross Profit Margin 6.05% 6.0%
Selling, General & Admin $15.73M $17.11M
YoY Change -10.34% 1.8%
% of Gross Profit 148.56% 144.3%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.782M $2.911M
YoY Change -21.3% -20.07%
% of Gross Profit 26.27% 24.55%
Operating Expenses $15.73M $17.11M
YoY Change -10.34% 1.8%
Operating Profit -$5.142M -$5.254M
YoY Change -84.15% 3.22%
Interest Expense $319.0K $325.0K
YoY Change -65.17% -12.63%
% of Operating Profit
Other Income/Expense, Net $2.454M $2.262M
YoY Change 407.02% -310.61%
Pretax Income -$2.845M -$3.167M
YoY Change -91.33% -51.37%
Income Tax $6.000K $0.00
% Of Pretax Income
Net Earnings -$2.851M -$3.167M
YoY Change -91.32% -51.37%
Net Earnings / Revenue -1.63% -1.6%
Basic Earnings Per Share -$0.10 -$0.12
Diluted Earnings Per Share -$0.10 -$0.12
COMMON SHARES
Basic Shares Outstanding 27.21M shares 27.21M shares
Diluted Shares Outstanding 27.38M shares 27.11M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $47.16M $27.40M
YoY Change 49.89% 91.05%
Cash & Equivalents $47.16M $27.36M
Short-Term Investments
Other Short-Term Assets $4.184M $3.235M
YoY Change -11.82% -41.71%
Inventory $8.441M $9.153M
Prepaid Expenses $8.470M $10.14M
Receivables $158.2M $152.3M
Other Receivables $449.0K $500.0K
Total Short-Term Assets $267.3M $245.0M
YoY Change -9.23% -5.97%
LONG-TERM ASSETS
Property, Plant & Equipment $42.49M $45.03M
YoY Change -16.17% -12.84%
Goodwill $29.13M $29.06M
YoY Change -2.02% -30.68%
Intangibles $2.202M $2.635M
YoY Change -43.98% -39.62%
Long-Term Investments
YoY Change
Other Assets $19.71M $14.87M
YoY Change 90.44% 140.49%
Total Long-Term Assets $137.5M $137.2M
YoY Change -4.26% -8.7%
TOTAL ASSETS
Total Short-Term Assets $267.3M $245.0M
Total Long-Term Assets $137.5M $137.2M
Total Assets $404.8M $382.3M
YoY Change -7.6% -6.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $61.89M $74.09M
YoY Change -23.18% 8.08%
Accrued Expenses $25.91M $24.20M
YoY Change -8.23% -26.12%
Deferred Revenue $117.3M $73.13M
YoY Change 17.55% 37.25%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $205.1M $171.4M
YoY Change -1.67% 10.87%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $10.00M
YoY Change -100.0% -33.33%
Other Long-Term Liabilities $2.178M $1.776M
YoY Change -90.57% -91.14%
Total Long-Term Liabilities $2.178M $1.776M
YoY Change -94.28% -94.93%
TOTAL LIABILITIES
Total Short-Term Liabilities $205.1M $171.4M
Total Long-Term Liabilities $2.178M $1.776M
Total Liabilities $225.9M $203.2M
YoY Change -8.41% 7.11%
SHAREHOLDERS EQUITY
Retained Earnings $52.90M $55.75M
YoY Change -26.47% -46.79%
Common Stock $279.0K $279.0K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $6.191M $7.372M
YoY Change -38.65% -35.99%
Treasury Stock Shares
Shareholders Equity $178.9M $179.1M
YoY Change
Total Liabilities & Shareholders Equity $404.8M $382.3M
YoY Change -7.6% -6.97%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$2.851M -$3.167M
YoY Change -91.32% -51.37%
Depreciation, Depletion And Amortization $2.782M $2.911M
YoY Change -21.3% -20.07%
Cash From Operating Activities $29.61M -$28.88M
YoY Change 67.81% -18.04%
INVESTING ACTIVITIES
Capital Expenditures $379.0K $478.0K
YoY Change -70.04% -69.71%
Acquisitions
YoY Change
Other Investing Activities $186.0K $2.620M
YoY Change 588.89% 65400.0%
Cash From Investing Activities -$193.0K $2.140M
YoY Change -84.41% -235.96%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -9.955M -$411.0K
YoY Change -14121.13% 67.76%
NET CHANGE
Cash From Operating Activities 29.61M -$28.88M
Cash From Investing Activities -193.0K $2.140M
Cash From Financing Activities -9.955M -$411.0K
Net Change In Cash 19.46M -$27.45M
YoY Change 18.11% -27.81%
FREE CASH FLOW
Cash From Operating Activities $29.61M -$28.88M
Capital Expenditures $379.0K $478.0K
Free Cash Flow $29.23M -$29.35M
YoY Change 78.46% -20.25%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Restructuring Charges
RestructuringCharges
1287000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 dei Amendment Flag
AmendmentFlag
false
CY2023Q3 dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
402000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1061000 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27888217 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27888217 shares
CY2023Q3 us-gaap Shares Outstanding
SharesOutstanding
27209838 shares
CY2023Q2 us-gaap Shares Outstanding
SharesOutstanding
27047318 shares
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
678379 shares
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
840899 shares
CY2023Q3 mtrx Deferred Shares Issued
DeferredSharesIssued
210243 shares
CY2022Q3 mtrx Deferred Shares Issued
DeferredSharesIssued
204827 shares
CY2023Q3 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
7601 shares
CY2022Q3 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
13033 shares
CY2023Q3 mtrx Other Treasury Shares Acquired
OtherTreasurySharesAcquired
55324 shares
CY2022Q3 mtrx Other Treasury Shares Acquired
OtherTreasurySharesAcquired
52864 shares
CY2023Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q3 dei Entity File Number
EntityFileNumber
1-15461
CY2023Q3 dei Entity Registrant Name
EntityRegistrantName
MATRIX SERVICE CO
CY2023Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q3 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
CY2023Q3 dei Trading Symbol
TradingSymbol
MTRX
CY2023Q3 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q3 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q3 dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
27213702 shares
CY2023Q3 us-gaap Restructuring Charges
RestructuringCharges
0 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5254000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5090000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
325000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
372000 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
150000 usd
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
24000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2262000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1074000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3167000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6512000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-3167000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-6512000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.24
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.24
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27113000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26862000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27113000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26862000 shares
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-3167000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-6512000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1753000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-3705000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-8265000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27359000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
54812000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
152300000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
145764000 usd
CY2023Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
42369000 usd
CY2023Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
44888000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
9153000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
7437000 usd
CY2023Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
496000 usd
CY2023Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
496000 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
10136000 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5741000 usd
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
3235000 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
3118000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
245048000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
262256000 usd
CY2023Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
25000000 usd
CY2023Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
25000000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
45027000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
47545000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
20641000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
21799000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
29055000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
29120000 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2635000 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3066000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
14872000 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
11718000 usd
CY2023Q3 us-gaap Assets
Assets
382278000 usd
CY2023Q2 us-gaap Assets
Assets
400504000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
74094000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
76365000 usd
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
73133000 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
85436000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
11511000 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
13679000 usd
CY2023Q3 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
5749000 usd
CY2023Q2 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
5579000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4281000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4661000 usd
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2641000 usd
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1815000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
171409000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
187535000 usd
CY2023Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
25000 usd
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
26000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
19945000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
20660000 usd
CY2023Q3 us-gaap Line Of Credit
LineOfCredit
10000000 usd
CY2023Q2 us-gaap Line Of Credit
LineOfCredit
10000000 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1776000 usd
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
799000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
203155000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
219020000 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
279000 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
279000 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
139773000 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
140810000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
55750000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
58917000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-9307000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-8769000 usd
CY2023Q3 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
186495000 usd
CY2023Q2 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
191237000 usd
CY2023Q3 us-gaap Treasury Stock Value
TreasuryStockValue
7372000 usd
CY2023Q2 us-gaap Treasury Stock Value
TreasuryStockValue
9753000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
179123000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
181484000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
382278000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
400504000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-3167000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-6512000 usd
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2911000 usd
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3642000 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
1755000 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
2055000 usd
CY2023Q3 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
2366000 usd
CY2022Q3 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-65000 usd
CY2023Q3 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-72000 usd
CY2022Q3 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
25000 usd
CY2023Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6543000 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4622000 usd
CY2023Q3 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-2519000 usd
CY2022Q3 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
14857000 usd
CY2023Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1716000 usd
CY2022Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1595000 usd
CY2023Q3 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
7669000 usd
CY2022Q3 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3370000 usd
CY2023Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2173000 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-6376000 usd
CY2023Q3 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-12303000 usd
CY2022Q3 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-11820000 usd
CY2023Q3 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-195000 usd
CY2022Q3 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-4248000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-28875000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-35229000 usd
CY2023Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
478000 usd
CY2022Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1578000 usd
CY2023Q3 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
2618000 usd
CY2022Q3 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
4000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2140000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1574000 usd
CY2023Q3 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
45000 usd
CY2022Q3 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
65000 usd
CY2023Q3 us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
456000 usd
CY2022Q3 us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
310000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-411000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-245000 usd
CY2023Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-307000 usd
CY2022Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-981000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-27453000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-38029000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
79812000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
77371000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
52359000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
39342000 usd
CY2023Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-27000 usd
CY2022Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q3 us-gaap Interest Paid Net
InterestPaidNet
389000 usd
CY2022Q3 us-gaap Interest Paid Net
InterestPaidNet
421000 usd
CY2023Q3 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
6000 usd
CY2022Q3 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
101000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
181484000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-3167000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-538000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
0 usd
CY2023Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
45000 usd
CY2023Q3 mtrx Other Treasury Share Purchases
OtherTreasurySharePurchases
456000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1755000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
179123000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-6512000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1753000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
0 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
0 usd
CY2022Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
65000 usd
CY2022Q3 mtrx Other Treasury Share Purchases
OtherTreasurySharePurchases
310000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2055000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
221251000 usd
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
376500000 usd
CY2023Q3 mtrx Performanceobligationstoberecognizedasrevenuewithinnexttwelvemonths
Performanceobligationstoberecognizedasrevenuewithinnexttwelvemonths
293100000 usd
CY2023Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
42369000 usd
CY2023Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
44888000 usd
CY2023Q3 mtrx Changein Cie
ChangeinCIE
-2519000 usd
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
73133000 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
85436000 usd
CY2023Q3 mtrx Changein Bie
ChangeinBIE
12303000 usd
CY2023Q3 mtrx Contractwithcustomercurrentliabilitynet
Contractwithcustomercurrentliabilitynet
-30764000 usd
CY2023Q2 mtrx Contractwithcustomercurrentliabilitynet
Contractwithcustomercurrentliabilitynet
-40548000 usd
CY2023Q3 mtrx Changeinnetcontractbalances
Changeinnetcontractbalances
9784000 usd
CY2023Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
62900000 usd
CY2023Q3 us-gaap Construction Contractor Receivable Retainage Year One
ConstructionContractorReceivableRetainageYearOne
15200000 usd
CY2023Q2 us-gaap Construction Contractor Receivable Retainage Year One
ConstructionContractorReceivableRetainageYearOne
16300000 usd
CY2023Q3 us-gaap Construction Contractor Receivable Retainage After Year One
ConstructionContractorReceivableRetainageAfterYearOne
13400000 usd
CY2023Q2 us-gaap Construction Contractor Receivable Retainage After Year One
ConstructionContractorReceivableRetainageAfterYearOne
10000000 usd
CY2023Q3 us-gaap Unapproved Change Orders Amount
UnapprovedChangeOrdersAmount
10100000 usd
CY2023Q2 us-gaap Unapproved Change Orders Amount
UnapprovedChangeOrdersAmount
9700000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
197659000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
208431000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
197659000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
208431000 usd
CY2023Q3 us-gaap Line Of Credit Facility Initiation Date1
LineOfCreditFacilityInitiationDate1
2021-09-09
CY2023Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
90000000 usd
CY2023Q3 us-gaap Line Of Credit Facility Increase Decrease For Period Net
LineOfCreditFacilityIncreaseDecreaseForPeriodNet
15000000 usd
CY2023Q3 us-gaap Compensating Balance Amount
CompensatingBalanceAmount
25000000 usd
CY2023Q3 us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2026-09-09
CY2023Q3 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
72900000 usd
CY2023Q3 us-gaap Line Of Credit
LineOfCredit
10000000 usd
CY2023Q3 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
10000000 usd
CY2023Q3 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
52900000 usd
CY2023Q3 mtrx Asset Backed Credit Facility Adjusted Term Sofr One Month Add On
AssetBackedCreditFacilityAdjustedTermSOFROneMonthAddOn
11.448
CY2023Q3 mtrx Asset Backed Credit Facility Adjusted Term Sofr Three Month Add On
AssetBackedCreditFacilityAdjustedTermSOFRThreeMonthAddOn
26.161
CY2023Q3 mtrx Asset Backed Credit Facility Federal Funds Rate Addition
AssetBackedCreditFacilityFederalFundsRateAddition
0.0050
CY2023Q3 mtrx Asset Backed Credit Facility Adjusted Term Sofr Rate Minimum
AssetBackedCreditFacilityAdjustedTermSOFRRateMinimum
0.0100
CY2023Q3 mtrx Alternate Base Rate Margin
AlternateBaseRateMargin
0.0100
CY2023Q3 mtrx Line Of Credit Basis Spread On Alternate Base Rate Minimum
LineOfCreditBasisSpreadOnAlternateBaseRateMinimum
0.0100
CY2023Q3 mtrx Line Of Credit Basis Spread On Alternate Base Rate Maximum
LineOfCreditBasisSpreadOnAlternateBaseRateMaximum
0.0150
CY2023Q3 mtrx Additional Margin On Adjusted Term Sofr Minimum
AdditionalMarginOnAdjustedTermSOFRMinimum
0.0200
CY2023Q3 mtrx Additional Margin On Adjusted Term Sofr Maximum
AdditionalMarginOnAdjustedTermSOFRMaximum
0.0250
CY2023Q3 us-gaap Line Of Credit Facility Unused Capacity Commitment Fee Percentage
LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
0.0025
CY2023Q3 us-gaap Line Of Credit Facility Interest Rate At Period End
LineOfCreditFacilityInterestRateAtPeriodEnd
0.0768
CY2023Q3 mtrx Mtrx Asset Backed Lineof Credit Balance Limitfor Fixed Charge Coverage Ratio
MtrxAssetBackedLineofCreditBalanceLimitforFixedChargeCoverageRatio
15000000 usd
CY2023Q3 mtrx Mtrx Asset Backed Lineof Credit Percentage Limitfor Fixed Charge Coverage Ratio
MtrxAssetBackedLineofCreditPercentageLimitforFixedChargeCoverageRatio
0.1500
CY2023Q3 mtrx Asset Backed Credit Facility Fixed Charge Coverage Ratio Requirement Minimum
AssetBackedCreditFacilityFixedChargeCoverageRatioRequirementMinimum
1.00
CY2023Q3 mtrx Asset Backed Credit Facility Fixed Charge Coverage Ratio Requirement Maximum
AssetBackedCreditFacilityFixedChargeCoverageRatioRequirementMaximum
1.00
CY2023Q3 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
200000 usd
CY2022Q3 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1400000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-3167000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-6512000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27113000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26862000 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.24
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-3167000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-6512000 usd
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27113000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26862000 shares
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.24
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
231 shares
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
95 shares
CY2023Q3 mtrx Grossrevenues
Grossrevenues
198512000 usd
CY2022Q3 mtrx Grossrevenues
Grossrevenues
208905000 usd
CY2023Q3 us-gaap Revenues
Revenues
197659000 usd
CY2022Q3 us-gaap Revenues
Revenues
208431000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
11859000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
13008000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
17113000 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
16811000 usd
CY2023Q3 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
0 usd
CY2022Q3 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
1287000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5254000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5090000 usd
CY2023Q3 us-gaap Assets
Assets
382278000 usd
CY2023Q2 us-gaap Assets
Assets
400504000 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
mtrx-20230930_cal.xml Edgar Link unprocessable
0000866273-23-000067-index-headers.html Edgar Link pending
0000866273-23-000067-index.html Edgar Link pending
0000866273-23-000067.txt Edgar Link pending
0000866273-23-000067-xbrl.zip Edgar Link pending
exhibit311-mtrxx2023x9x30x.htm Edgar Link pending
exhibit312-mtrxx2023x9x30x.htm Edgar Link pending
exhibit321-mtrxx2023x9x30x.htm Edgar Link pending
exhibit322-mtrxx2023x9x30x.htm Edgar Link pending
exhibit95-mtrxx2023x9x30x.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mtrx-20230930.htm Edgar Link pending
mtrx-20230930.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
mtrx-20230930_def.xml Edgar Link unprocessable
mtrx-20230930_lab.xml Edgar Link unprocessable
mtrx-20230930_pre.xml Edgar Link unprocessable
mtrx-20230930_htm.xml Edgar Link completed